checkAd

     164  0 Kommentare Health Canada Issues an Interim Order for Spectral Medical’s PMX to Treat COVID-19 Patients - Seite 3

    The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this statement.

    For further information, please contact:

    Dr. Paul Walker
    President and CEO
    Spectral Medical Inc.
    416-626-3233 ext. 2100
    pwalker@spectraldx.com
    Mr. Chris Seto
    CFO
    Spectral Medical Inc.
    416-626-3233 ext. 2004
    cseto@spectraldx.com
    Ali Mahdavi
    Capital Markets & Investor Relations
    416-962-3300
    am@spinnakercmi.com

    globenewswire
    0 Follower
    Autor folgen
    Seite 3 von 3

    Verfasst von globenewswire
    Health Canada Issues an Interim Order for Spectral Medical’s PMX to Treat COVID-19 Patients - Seite 3 PMX has successfully been used for treatment in COVID-19 patients in the U.S., Japan and Italy Interim Order expands already approved PMX Health Canada indications for use to include treatment of COVID-19 patients TORONTO, April 20, 2020 (GLOBE …